Does the media favor LIF or KSPI?

In the previous week, Life360 had 4 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 10 mentions for Life360 and 6 mentions for Joint Stock Company Kaspi.kz. Life360's average media sentiment score of 0.76 beat Joint Stock Company Kaspi.kz's score of 0.74 indicating that Life360 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Joint Stock Company Kaspi.kz 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, TOST or LIF?

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Toast $6.15B 2.59 $342M $0.65 47.52 Life360 $489.48M 8.93 $150.83M $1.73 31.17

Is TOST or LIF more profitable?

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Toast 6.39% 20.86% 13.84% Life360 28.21% 6.80% 3.65%

Does the media refer more to TOST or LIF?

In the previous week, Toast and Toast both had 10 articles in the media. Toast's average media sentiment score of 1.31 beat Life360's score of 0.76 indicating that Toast is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Toast 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life360 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, TRU or LIF?

TransUnion has higher revenue and earnings than Life360. TransUnion is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransUnion $4.73B 3.22 $455.40M $3.61 21.90 Life360 $489.48M 8.93 $150.83M $1.73 31.17

Is TRU or LIF more profitable?

Life360 has a net margin of 28.21% compared to TransUnion's net margin of 14.91%. TransUnion's return on equity of 16.09% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets TransUnion 14.91% 16.09% 6.62% Life360 28.21% 6.80% 3.65%

Does the media prefer TRU or LIF?

In the previous week, Life360 had 2 more articles in the media than TransUnion. MarketBeat recorded 10 mentions for Life360 and 8 mentions for TransUnion. TransUnion's average media sentiment score of 1.21 beat Life360's score of 0.76 indicating that TransUnion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransUnion 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life360 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, LIF or RTO?

Rentokil Initial has higher revenue and earnings than Life360. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 8.93 $150.83M $1.73 31.17 Rentokil Initial $6.91B 2.20 $470M N/A N/A

Does the media favor LIF or RTO?

In the previous week, Life360 had 6 more articles in the media than Rentokil Initial. MarketBeat recorded 10 mentions for Life360 and 4 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 0.79 beat Life360's score of 0.76 indicating that Rentokil Initial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Rentokil Initial 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, LIF or MEDP?

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 8.93 $150.83M $1.73 31.17 Medpace $2.53B 5.96 $451.12M $15.91 33.18

Is LIF or MEDP more profitable?

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Life360 28.21% 6.80% 3.65% Medpace 17.19% 120.89% 24.79%

Does the media favor LIF or MEDP?

In the previous week, Life360 had 2 more articles in the media than Medpace. MarketBeat recorded 10 mentions for Life360 and 8 mentions for Medpace. Medpace's average media sentiment score of 1.24 beat Life360's score of 0.76 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Life360 (LIF) Competitors

$53.93 +0.14 (+0.26%)

Closing price 07/20/2026 04:00 PM Eastern

Extended Trading

$54.74 +0.81 (+1.51%)

As of 08:09 AM Eastern

Compare

LIF vs. KSPI, TOST, TRU, RTO, and MEDP

Should you buy Life360 stock or one of its competitors? MarketBeat compares Life360 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Life360 include Joint Stock Company Kaspi.kz (KSPI), Toast (TOST), TransUnion (TRU), Rentokil Initial (RTO), and Medpace (MEDP). These companies are all part of the "business services" industry.

How does Life360 compare to Joint Stock Company Kaspi.kz?

Life360 (NASDAQ:LIF) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Life360 has a net margin of 28.21% compared to Joint Stock Company Kaspi.kz's net margin of 24.89%. Joint Stock Company Kaspi.kz's return on equity of 43.80% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Joint Stock Company Kaspi.kz	24.89%	43.80%	10.03%

Joint Stock Company Kaspi.kz has higher revenue and earnings than Life360. Joint Stock Company Kaspi.kz is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	8.93	$150.83M	$1.73	31.17
Joint Stock Company Kaspi.kz	$7.70B	2.18	$2.04B	$10.84	8.13

Life360 has a beta of 2.34, meaning that its stock price is 134% more volatile than the broader market. Comparatively, Joint Stock Company Kaspi.kz has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Life360 currently has a consensus target price of $64.81, indicating a potential upside of 20.17%. Joint Stock Company Kaspi.kz has a consensus target price of $96.67, indicating a potential upside of 9.66%. Given Life360's higher possible upside, analysts plainly believe Life360 is more favorable than Joint Stock Company Kaspi.kz.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58
Joint Stock Company Kaspi.kz	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Life360 had 4 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 10 mentions for Life360 and 6 mentions for Joint Stock Company Kaspi.kz. Life360's average media sentiment score of 0.76 beat Joint Stock Company Kaspi.kz's score of 0.74 indicating that Life360 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Joint Stock Company Kaspi.kz	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.0% of Life360 shares are owned by institutional investors. Comparatively, 32.2% of Joint Stock Company Kaspi.kz shares are owned by institutional investors. 6.8% of Life360 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Life360 beats Joint Stock Company Kaspi.kz on 9 of the 16 factors compared between the two stocks.

How does Life360 compare to Toast?

Toast (NYSE:TOST) and Life360 (NASDAQ:LIF) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

Toast currently has a consensus price target of $36.96, suggesting a potential upside of 19.66%. Life360 has a consensus price target of $64.81, suggesting a potential upside of 20.17%. Given Life360's higher probable upside, analysts clearly believe Life360 is more favorable than Toast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Toast	0 Sell rating(s)	8 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	2.77
Life360	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

Toast has a beta of 1.74, suggesting that its stock price is 74% more volatile than the broader market. Comparatively, Life360 has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market.

82.9% of Toast shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. 10.0% of Toast shares are owned by company insiders. Comparatively, 6.8% of Life360 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Toast and Toast both had 10 articles in the media. Toast's average media sentiment score of 1.31 beat Life360's score of 0.76 indicating that Toast is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Toast	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Toast	6.39%	20.86%	13.84%
Life360	28.21%	6.80%	3.65%

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Toast	$6.15B	2.59	$342M	$0.65	47.52
Life360	$489.48M	8.93	$150.83M	$1.73	31.17

Summary

Toast beats Life360 on 11 of the 16 factors compared between the two stocks.

How does Life360 compare to TransUnion?

TransUnion (NYSE:TRU) and Life360 (NASDAQ:LIF) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

TransUnion has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market. Comparatively, Life360 has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market.

In the previous week, Life360 had 2 more articles in the media than TransUnion. MarketBeat recorded 10 mentions for Life360 and 8 mentions for TransUnion. TransUnion's average media sentiment score of 1.21 beat Life360's score of 0.76 indicating that TransUnion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransUnion	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

20.0% of Life360 shares are held by institutional investors. 0.4% of TransUnion shares are held by insiders. Comparatively, 6.8% of Life360 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Life360 has a net margin of 28.21% compared to TransUnion's net margin of 14.91%. TransUnion's return on equity of 16.09% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransUnion	14.91%	16.09%	6.62%
Life360	28.21%	6.80%	3.65%

TransUnion currently has a consensus target price of $91.60, suggesting a potential upside of 15.87%. Life360 has a consensus target price of $64.81, suggesting a potential upside of 20.17%. Given Life360's higher possible upside, analysts plainly believe Life360 is more favorable than TransUnion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransUnion	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.64
Life360	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

TransUnion has higher revenue and earnings than Life360. TransUnion is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransUnion	$4.73B	3.22	$455.40M	$3.61	21.90
Life360	$489.48M	8.93	$150.83M	$1.73	31.17

Summary

TransUnion and Life360 tied by winning 8 of the 16 factors compared between the two stocks.

How does Life360 compare to Rentokil Initial?

Life360 (NASDAQ:LIF) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

20.0% of Life360 shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 6.8% of Life360 shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Life360 presently has a consensus target price of $64.81, suggesting a potential upside of 20.17%. Rentokil Initial has a consensus target price of $34.50, suggesting a potential upside of 14.60%. Given Life360's stronger consensus rating and higher probable upside, equities analysts plainly believe Life360 is more favorable than Rentokil Initial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58
Rentokil Initial	2 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.54

Life360 has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, Rentokil Initial has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

In the previous week, Life360 had 6 more articles in the media than Rentokil Initial. MarketBeat recorded 10 mentions for Life360 and 4 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 0.79 beat Life360's score of 0.76 indicating that Rentokil Initial is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Rentokil Initial	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Rentokil Initial has higher revenue and earnings than Life360.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	8.93	$150.83M	$1.73	31.17
Rentokil Initial	$6.91B	2.20	$470M	N/A	N/A

Life360 has a net margin of 28.21% compared to Rentokil Initial's net margin of 0.00%. Life360's return on equity of 6.80% beat Rentokil Initial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Rentokil Initial	N/A	N/A	N/A

Summary

Life360 beats Rentokil Initial on 10 of the 14 factors compared between the two stocks.

How does Life360 compare to Medpace?

Life360 (NASDAQ:LIF) and Medpace (NASDAQ:MEDP) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Life360 currently has a consensus target price of $64.81, suggesting a potential upside of 20.17%. Medpace has a consensus target price of $469.50, suggesting a potential downside of 11.07%. Given Life360's stronger consensus rating and higher probable upside, equities analysts plainly believe Life360 is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58
Medpace	1 Sell rating(s)	12 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.07

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	8.93	$150.83M	$1.73	31.17
Medpace	$2.53B	5.96	$451.12M	$15.91	33.18

In the previous week, Life360 had 2 more articles in the media than Medpace. MarketBeat recorded 10 mentions for Life360 and 8 mentions for Medpace. Medpace's average media sentiment score of 1.24 beat Life360's score of 0.76 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.0% of Life360 shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 6.8% of Life360 shares are owned by company insiders. Comparatively, 20.5% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Medpace	17.19%	120.89%	24.79%

Life360 has a beta of 2.34, suggesting that its share price is 134% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Summary

Medpace beats Life360 on 9 of the 17 factors compared between the two stocks.

Get Life360 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LIF vs. The Competition

Export

Metric	Life360	PROTECTION Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$4.36B	$3.35B	$9.36B	$12.28B
Dividend Yield	N/A	1.82%	3.51%	9.39%
P/E Ratio	31.17	20.27	26.77	23.95
Price / Sales	8.93	4.08	2,000.61	90.33
Price / Cash	N/A	28.10	27.26	47.25
Price / Book	7.72	3.44	4.40	6.14
Net Income	$150.83M	$107.80M	$792.80M	$331.74M
7 Day Performance	1.75%	-1.37%	-0.11%	-1.82%
1 Month Performance	10.02%	-3.07%	0.47%	-1.45%
1 Year Performance	-27.72%	-20.04%	14.15%	16.32%

Life360 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LIF Life360	2.3069 of 5 stars	$53.93 +0.3%	$64.81 +20.2%	-27.5%	$4.36B	$489.48M	31.17	600	Analyst Forecast Gap Down
KSPI Joint Stock Company Kaspi.kz	4.6595 of 5 stars	$87.49 +0.0%	$96.67 +10.5%	+2.5%	$16.63B	$7.70B	8.07	14,008	Upcoming Earnings
TOST Toast	4.3618 of 5 stars	$29.84 -1.6%	$36.96 +23.9%	-33.7%	$15.41B	$6.15B	45.95	6,500	Positive News
TRU TransUnion	4.6632 of 5 stars	$79.43 -1.6%	$91.60 +15.3%	-15.7%	$15.32B	$4.58B	22.00	13,500	Positive News Upcoming Earnings
RTO Rentokil Initial	4.2361 of 5 stars	$30.31 -0.3%	$34.50 +13.8%	+26.4%	$15.31B	$6.91B	N/A	63,388	News Coverage Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LIF) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Life360 (LIF) Competitors

LIF vs. KSPI, TOST, TRU, RTO, and MEDP

How does Life360 compare to Joint Stock Company Kaspi.kz?

Summary

How does Life360 compare to Toast?

Summary

How does Life360 compare to TransUnion?

Summary

How does Life360 compare to Rentokil Initial?

Summary

How does Life360 compare to Medpace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Life360 (LIF) Competitors

LIF vs. KSPI, TOST, TRU, RTO, and MEDP

How does Life360 compare to Joint Stock Company Kaspi.kz?

Is LIF or KSPI more profitable?

Which has stronger earnings and valuation, LIF or KSPI?

Which has more risk and volatility, LIF or KSPI?

Do analysts recommend LIF or KSPI?

Does the media favor LIF or KSPI?

Do institutionals and insiders believe in LIF or KSPI?

Summary

How does Life360 compare to Toast?

Do analysts prefer TOST or LIF?

Which has more volatility & risk, TOST or LIF?

Do institutionals & insiders have more ownership in TOST or LIF?

Does the media refer more to TOST or LIF?

Is TOST or LIF more profitable?

Which has higher valuation & earnings, TOST or LIF?

Summary

How does Life360 compare to TransUnion?

Which has more risk & volatility, TRU or LIF?

Does the media prefer TRU or LIF?

Do insiders & institutionals have more ownership in TRU or LIF?

Is TRU or LIF more profitable?

Do analysts recommend TRU or LIF?

Which has stronger valuation & earnings, TRU or LIF?

Summary

How does Life360 compare to Rentokil Initial?

Do insiders and institutionals hold more shares of LIF or RTO?

Do analysts rate LIF or RTO?

Which has more risk & volatility, LIF or RTO?

Does the media favor LIF or RTO?

Which has higher earnings & valuation, LIF or RTO?

Is LIF or RTO more profitable?

Summary

How does Life360 compare to Medpace?

Do analysts recommend LIF or MEDP?

Which has higher valuation and earnings, LIF or MEDP?

Does the media favor LIF or MEDP?

Do institutionals & insiders have more ownership in LIF or MEDP?

Is LIF or MEDP more profitable?

Which has more volatility and risk, LIF or MEDP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools